NRx Pharmaceuticals (NRXP) Short Interest Ratio & Short Volume $3.01 -0.10 (-3.22%) Closing price 04:00 PM EasternExtended Trading$3.10 +0.10 (+3.16%) As of 06:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NRx Pharmaceuticals Short Interest DataNRx Pharmaceuticals (NRXP) has a short interest of 901,900 shares, representing 5.58% of the float (the number of shares available for trading by the public). This marks a -24.84% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.6, indicating that it would take 3.6 days of the average trading volume of 422,053 shares to cover all short positions.Current Short Interest901,900 sharesPrevious Short Interest1,200,000 sharesChange Vs. Previous Month-24.84%Dollar Volume Sold Short$2.94 millionShort Interest Ratio3.6 Days to CoverLast Record DateJune 30, 2025Outstanding Shares17,290,000 sharesFloat Size16,170,000 sharesShort Percent of Float5.58%Today's Trading Volume190,873 sharesAverage Trading Volume422,053 sharesToday's Volume Vs. Average45% Short Selling NRx Pharmaceuticals? Sign up to receive the latest short interest report for NRx Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNRXP Short Interest Over TimeNRXP Days to Cover Over TimeNRXP Percentage of Float Shorted Over Time NRx Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/2025901,900 shares $2.94 million -24.8%5.6%3.6 $3.26 6/15/20251,200,000 shares $4.13 million +8.1%7.4%4.8 $3.44 5/31/20251,110,000 shares $2.91 million No Change7.7%4.5 $2.62 5/15/20251,110,000 shares $2.66 million -8.3%7.7%4.9 $2.40 4/30/20251,210,000 shares $2.57 million -2.4%8.5%6.4 $2.12 4/15/20251,240,000 shares $2.44 million -4.6%8.8%4.5 $1.97 3/31/20251,300,000 shares $2.67 million +26.2%9.3%2.1 $2.05 3/15/20251,030,000 shares $2.42 million -12.0%7.3%0.9 $2.35 2/28/20251,170,000 shares $2.66 million +1.7%9.1%1 $2.27 2/15/20251,150,000 shares $3.28 million +11.7%8.9%1 $2.85 Get the Latest News and Ratings for NRXP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NRx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/20251,030,000 shares $3.11 million -14.9%8.6%0.9 $3.02 1/15/20251,210,000 shares $5.43 million +88.2%13.2%1.2 $4.49 12/31/2024643,000 shares $1.41 million +7.2%7.0%0.7 $2.20 12/15/2024599,800 shares $719.76 thousand +6.0%6.5%2.9 $1.20 11/30/2024565,800 shares $741.20 thousand -15.2%6.4%3.9 $1.31 11/15/2024667,000 shares $793.73 thousand -2.3%7.5%5.1 $1.19 10/31/2024682,700 shares $935.30 thousand +20.4%8.6%5.9 $1.37 10/15/2024567,000 shares $680.40 thousand +6.6%7.2%5.8 $1.20 9/30/2024532,100 shares $899.25 thousand +24.8%6.7%6.7 $1.69 9/15/2024426,500 shares $733.58 thousand -14.9%5.4%5.3 $1.72 8/31/2024501,000 shares $936.87 thousand +5.6%6.3%6.8 $1.87 8/15/2024474,600 shares $825.80 thousand +41.3%5.9%5.3 $1.74 7/31/2024336,000 shares $769.44 thousand +13.8%4.8%2.6 $2.29 7/15/2024295,200 shares $705.53 thousand -2.2%4.2%0.9 $2.39 6/30/2024301,700 shares $736.15 thousand -15.5%4.3%0.8 $2.44 6/15/2024357,200 shares $1.08 million +13.0%5.1%0.9 $3.03 5/31/2024316,200 shares $1.20 million -35.2%4.5%0.8 $3.81 5/15/2024487,900 shares $1.58 million +0.4%7.0%1.1 $3.23 4/30/2024486,200 shares $1.25 million -4.8%6.4%1.2 $2.58 4/15/2024510,800 shares $2.50 million +20.3%6.7%2.5 $4.90 3/31/2024424,500 shares $20.03 million -88.6%6.7%2.7 $47.19 3/15/20243,710,000 shares $1.69 million +36.9%6.0%2.6 $0.46 2/29/20242,710,000 shares $972.89 thousand -30.0%4.4%1.7 $0.36 2/15/20243,870,000 shares $1.87 million +34.8%6.8%3.6 $0.48 1/31/20242,870,000 shares $1.06 million -1.7%5.1%3.2 $0.37 1/15/20242,920,000 shares $1.25 million +9.0%5.2%3.5 $0.43 12/31/20232,680,000 shares $1.23 million +101.5%4.7%3.2 $0.46 12/15/20231,330,000 shares $450.87 thousand -9.5%2.3%1.5 $0.34 11/30/20231,470,000 shares $505.68 thousand -4.6%2.6%2.6 $0.34 11/15/20231,540,000 shares $500.50 thousand -1.9%2.8%1.4 $0.33"Death Spiral" Threatening Your Savings (Ad)The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Click Here to Keep Reading...National Debt & Your Retirement 10/31/20231,570,000 shares $510.25 thousand -17.4%2.9%1.1 $0.33 10/15/20231,900,000 shares $522.69 thousand -11.2%3.5%1.3 $0.28 9/30/20232,140,000 shares $556.40 thousand +46.6%3.9%1.5 $0.26 9/15/20231,460,000 shares $416.10 thousand +1.4%2.7%1.1 $0.29 8/31/20231,440,000 shares $424.94 thousand +79.8%2.9%1.2 $0.30 8/15/2023801,000 shares $272.26 thousand -24.4%1.6%1.1 $0.34 7/31/20231,060,000 shares $413.51 thousand -12.4%2.5%2.5 $0.39 7/15/20231,210,000 shares $447.70 thousand +37.1%2.9%3.4 $0.37 6/30/2023882,300 shares $426.59 thousand -25.2%2.1%2.9 $0.48 6/15/20231,180,000 shares $625.40 thousand -7.1%2.8%3.9 $0.53 5/31/20231,270,000 shares $889 thousand -5.9%3.0%4.7 $0.70 5/15/20231,350,000 shares $940.28 thousand -12.3%3.2%9.3 $0.70 4/30/20231,540,000 shares $895.05 thousand -3.1%3.5%10.6 $0.58 4/15/20231,590,000 shares $983.42 thousand -1.2%3.7%10.4 $0.62 3/31/20231,610,000 shares $1.06 million +14.2%3.8%8.4 $0.66 3/15/20231,410,000 shares $958.80 thousand +12.8%3.4%6.7 $0.68 2/28/20231,250,000 shares $1.28 million +9.7%3.2%4.9 $1.02 2/15/20231,140,000 shares $1.22 million -3.4%2.9%3.8 $1.07 1/31/20231,180,000 shares $1.38 million -9.9%3.0%3.2 $1.17 1/15/20231,310,000 shares $1.83 million -7.1%3.3%3.5 $1.40 12/30/20221,410,000 shares $1.57 million -7.2%3.6%4 $1.11 12/15/20221,520,000 shares $1.66 million +3.4%3.8%4.6 $1.09 11/30/20221,470,000 shares $2.12 million +12.2%4.0%4.6 $1.44 11/15/20221,310,000 shares $1.22 million +3.2%3.6%4.6 $0.93 10/31/20221,270,000 shares $1.03 million -13.6%3.4%3.6 $0.81 10/15/20221,470,000 shares $1.11 million -9.8%4.0%0.6 $0.75 9/30/20221,630,000 shares $1.21 million +25.4%4.4%0.7 $0.74 9/15/20221,300,000 shares $1.03 million -19.3%3.5%0.5 $0.79 8/31/20221,610,000 shares $1.05 million +1.3%4.4%0.6 $0.65 8/15/20221,590,000 shares $1.19 million +0.6%4.3%0.5 $0.75 7/31/20221,580,000 shares $1.25 million +3.3%4.4%0.5 $0.79 7/15/20221,530,000 shares $838.44 thousand -8.9%4.2%1.4 $0.55 6/30/20221,680,000 shares $1.01 million +8.4%4.6%1.4 $0.60 6/15/20221,550,000 shares $802.90 thousand -22.1%4.5%1.3 $0.52 5/31/20221,990,000 shares $1.11 million +3.1%5.9%1.6 $0.56 5/15/20221,930,000 shares $2.55 million -25.2%5.7%3.2 $1.32 4/30/20222,580,000 shares $4.02 million -29.5%7.6%3.8 $1.56 4/15/20223,660,000 shares $8.86 million +3.4%10.8%5 $2.42 3/31/20223,540,000 shares $8.67 million +20.8%12.0%4.4 $2.45 3/15/20222,930,000 shares $9.08 million +3.5%9.9%2.9 $3.10 2/28/20222,830,000 shares $8.46 million +15.5%9.6%2.5 $2.99 2/15/20222,450,000 shares $7.45 million +15.6%9.4%0.9 $3.04 1/31/20222,120,000 shares $6.30 million +38.6%8.1%0.7 $2.97 1/15/20221,530,000 shares $6.67 million -31.7%5.9%0.5 $4.36 12/31/20212,240,000 shares $10.71 million +40.0%8.6%0.5 $4.78 12/15/20211,600,000 shares $8.72 million -16.7%6.1%0.4 $5.45 11/30/20211,920,000 shares $12.83 million +62.7%8.4%0.4 $6.68 11/15/20211,180,000 shares $7.32 million -29.3%5.1%0.4 $6.20 10/29/20211,670,000 shares $16.92 million -12.6%8.3%0.6 $10.13 10/15/20211,910,000 shares $19.60 million +12.4%9.5%0.5 $10.26"Death Spiral" Threatening Your Savings (Ad)The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Click Here to Keep Reading...National Debt & Your Retirement 9/30/20211,700,000 shares $15.76 million -20.9%8.4%0.3 $9.27 9/15/20212,150,000 shares $24.90 million -4.9%12.9%0.4 $11.58 8/31/20212,260,000 shares $35.48 million +119.4%12.1%0.5 $15.70 8/13/20211,030,000 shares $15.68 million No Change6.1%0.2 $15.22 NRXP Short Interest - Frequently Asked Questions What is NRx Pharmaceuticals' current short interest? Short interest is the volume of NRx Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of June 30th, traders have sold 901,900 shares of NRXP short. 5.58% of NRx Pharmaceuticals' shares are currently sold short. Learn More on NRx Pharmaceuticals' current short interest. What is a good short interest ratio for NRx Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NRXP shares currently have a short interest ratio of 4.0. Learn More on NRx Pharmaceuticals's short interest ratio. Which institutional investors are shorting NRx Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of NRx Pharmaceuticals: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for NRx Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.58% of NRx Pharmaceuticals' floating shares are currently sold short. Is NRx Pharmaceuticals' short interest increasing or decreasing? NRx Pharmaceuticals saw a decline in short interest in the month of June. As of June 30th, there was short interest totaling 901,900 shares, a decline of 24.8% from the previous total of 1,200,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is NRx Pharmaceuticals' float size? NRx Pharmaceuticals currently has issued a total of 17,290,000 shares. Some of NRx Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. NRx Pharmaceuticals currently has a public float of 16,170,000 shares. How does NRx Pharmaceuticals' short interest compare to its competitors? 5.58% of NRx Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to NRx Pharmaceuticals: MediWound Ltd. (11.95%), biote Corp. (2.97%), Larimar Therapeutics, Inc. (10.24%), Canopy Growth Corporation (10.18%), AC Immune (2.31%), Neumora Therapeutics, Inc. (16.13%), 4D Molecular Therapeutics, Inc. (9.29%), Eupraxia Pharmaceuticals Inc. (0.62%), Ventyx Biosciences, Inc. (0.01%), Organigram Global Inc. (6.22%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short NRx Pharmaceuticals stock? Short selling NRXP is an investing strategy that aims to generate trading profit from NRx Pharmaceuticals as its price is falling. NRXP shares are trading down $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against NRx Pharmaceuticals? A short squeeze for NRx Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NRXP, which in turn drives the price of the stock up even further. How often is NRx Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NRXP, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies MDWD Short Interest Data BTMD Short Interest Data LRMR Short Interest Data CGC Short Interest Data ACIU Short Interest Data NMRA Short Interest Data FDMT Short Interest Data EPRX Short Interest Data VTYX Short Interest Data OGI Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NRXP) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NRx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NRx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NRXP Stock Alerts